Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas

Journal of Neurosurgery - Tập 86 Số 5 - Trang 747-754 - 1997
R J Packer1, Joann L. Ater, Jeffrey C. Allen, Peter C. Phillips∥, Russ Geyer, H. Stacy Nicholson, R. I. Jakacki, Elizabeth Kurczynski, Michael N. Needle, Jonathan L. Finlay, Gregory H. Reaman, James M. Boyett
1Department of Neurology, Children's National Medical Center, George Washington University, Washington, D.C. 20010, USA.

Tóm tắt

✓ The optimum treatment of nonresectable low-grade gliomas of childhood remains undecided. There has been increased interest in the use of chemotherapy for young children, but little information concerning the long-term efficacy of such treatment. Seventy-eight children with a mean age of 3 years (range 3 months—16 years) who had newly diagnosed, progressive low-grade gliomas were treated with combined carboplatin and vincristine chemotherapy. The patients were followed for a median of 30 months from diagnosis, with 31 patients followed for more than 3 years. Fifty-eight children had diencephalic tumors, 12 had brainstem gliomas, and three had diffuse leptomeningeal gliomas. Forty-four (56%) of 78 patients showed an objective response to treatment. Progression-free survival rates were 75 ± 6% at 2 years and 68 ± 7% at 3 years. There was no statistical difference in progression-free survival rates between children with neurofibromatosis Type 1 and those without the disease (2-year, progression-free survival 79 ± 11% vs. 75 ± 6%, respectively). The histological subtype of the tumor, its location, and its maximum response to chemotherapy did not have an impact on the duration of disease control. The only significant prognostic factor was age: children 5 years old or younger at the time of treatment had a 3-year progression-free survival rate of 74 ± 7% compared with a rate of 39 ± 21% in older children (p < 0.01). Treatment with carboplatin and vincristine is effective, especially in younger children, in controlling newly diagnosed progressive low-grade gliomas.

Từ khóa


Tài liệu tham khảo

10.3171/jns.1988.68.1.0085

Anderson JR, 1983, J Clin Oncol, 1, 710, 10.1200/JCO.1983.1.11.710

10.1002/1097-0142(19910601)67:11<2772::AID-CNCR2820671110>3.0.CO;2-#

10.3171/jns.1986.65.2.0154

Friedman HS, 1992, J Clin Oncol, 10, 249, 10.1200/JCO.1992.10.2.249

Gilles F, 1988, J Neurooncol, 6, 9, 10.1007/BF00163535

10.3171/jns.1978.49.2.0179

Heideman RL, 1989, Principles and Practice of Pediatric Oncology., 505

10.3171/jns.1989.70.4.0568

Hoffman HJ, 1993, Neurosurgery, 33, 964, 10.1227/00006123-199312000-00002

10.1002/1097-0142(19950215)75:4<1051::AID-CNCR2820750423>3.0.CO;2-S

10.2307/2281868

Kleihues P, 1993, Histologic Typing of Tumours of the Central Nervous System., 10.1007/978-3-642-84988-6

10.1002/1097-0142(19880301)61:5<896::AID-CNCR2820610507>3.0.CO;2-C

10.3171/jns.1993.79.2.0223

Packer RJ, 1988, Neurofibromatosis, 1, 212

Packer RJ, 1993, J Clin Oncol, 11, 850, 10.1200/JCO.1993.11.5.850

10.1002/ana.410230113

Peto R, 1976, Br J Cancer, 34, 585, 10.1038/bjc.1976.220

10.3171/jns.1991.74.5.0701

Pons MA, 1992, J Neurooncol, 14, 151

10.1016/S0161-6420(82)34650-3

Shaw EG, 1989, Int J Radiat Oncol Biol Phys, 16, 663, 10.1016/0360-3016(89)90482-3

Sumner T, 1978, J Surg Oncol, 10, 45, 10.1002/jso.2930100108

10.3171/jns.1995.83.4.0583

Taveras JM, 1956, Radiology, 66, 518, 10.1148/66.4.518

10.3171/jns.1990.73.5.0661

Thông tin
Thông tin xuất bản

Journal of Neurosurgery

Tập 86 Số 5

747-754

Thông tin tác giả